Cargando…

The Effects of Chlormadinone Acetate on Lower Urinary Tract Symptoms and Erectile Functions of Patients with Benign Prostatic Hyperplasia: A Prospective Multicenter Clinical Study

Purpose. To evaluate the effects of chlormadinone acetate (CMA), progesterone-derived antiandrogen, on lower urinary tract symptoms (LUTS) and erectile functions of benign prostatic hyperplasia (BPH). Methods. A multicenter, single-cohort prospective study was conducted. A total of 114 patients rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujimoto, Kiyohide, Hirao, Yoshihiko, Ohashi, Yasuo, Shibata, Yasuhiro, Fuji, Kohzo, Tsuji, Hidenori, Miyazawa, Katsuhito, Ohtani, Mikinobu, Furuya, Ryoji, Boku, Eitetsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671298/ https://www.ncbi.nlm.nih.gov/pubmed/23762042 http://dx.doi.org/10.1155/2013/584678

Ejemplares similares

Ethinylestradiol/Chlormadinone Acetate: Dermatological Benefits
por: Guerra-Tapia, Aurora, et al.
Publicado: (2012)

Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
por: Vázquez, Mercedes Gómez, et al.
Publicado: (2012)

Chlormadinone acetate is effective for hot flush during androgen deprivation therapy
por: Koike, Hidekazu, et al.
Publicado: (2013)

A randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study
por: Sugimoto, Mikio, et al.
Publicado: (2021)

Clinical utility of chlormadinone acetate (Lutoral™) in frozen‐thawed embryo transfer with hormone replacement
por: Asada, Yoshimasa, et al.
Publicado: (2019)

The effect of chlormadinone acetate on odontogenic differentiation of human dental pulp cells: in vitro study
por: Kim, Se-Min, et al.
Publicado: (2017)

Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results
por: Shibasaki, Sena, et al.
Publicado: (2023)

Combined oral contraceptives containing chlormadinone acetate and breast cancer: results of a case-control study.
por: Ebeling, K., et al.
Publicado: (1991)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
por: Podfigurna, A., et al.
Publicado: (2019)

A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial
por: Jaisamrarn, Unnop, et al.
Publicado: (2018)

Transverse testicular ectopia with disorders of sex development
por: Aoki, Katsuya, et al.
Publicado: (2012)

Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction
por: Kardasevic, Amel, et al.
Publicado: (2017)

The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia
por: Oka, Anak Agung Gde, et al.
Publicado: (2019)

Generation, repair and replication of guanine oxidation products
por: Kino, Katsuhito, et al.
Publicado: (2017)

Products of Oxidative Guanine Damage Form Base Pairs with Guanine
por: Kino, Katsuhito, et al.
Publicado: (2020)

Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model
por: Inoue, Takeshi, et al.
Publicado: (2013)

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer
por: Tanaka, Nobumichi, et al.
Publicado: (2012)

The Effect of Transurethral Resection of the Prostate on Erectile Function in Patients with Benign Prostatic Hyperplasia
por: Choi, Seong Beom, et al.
Publicado: (2010)

Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
por: Shin, Yu Seob, et al.
Publicado: (2019)

Prostate and renal cancer, benign prostatic hyperplasia, erectile dysfunction and basic research : an update
Publicado: (2003)

The Correlation Between Prostate Volume in Patients with Benign Prostatic Hyperplasia in Relation to Erectile Dysfunction
por: Kardasevic, Amel, et al.
Publicado: (2016)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
por: Qalawena, Muhammed M., et al.
Publicado: (2020)

Diagnostic markers of urothelial cancer based on DNA methylation analysis
por: Chihara, Yoshitomo, et al.
Publicado: (2013)

Improvement of the surgical curability of locally confined prostate cancer including non-organ-confined high-risk disease through retropubic radical prostatectomy with intentional wide resection
por: Okajima, Eijiro, et al.
Publicado: (2012)

A new nomogram of urinary flow rate and volume based on multiple measurements per healthy adult Japanese men using a portable uroflowmeter (P-Flowdiary®)
por: Shinohara, Masatake, et al.
Publicado: (2022)

Validity of Short‐term Examination for Antipromoters of Bladder Carcinogenesis
por: Kakizoe, Tadao, et al.
Publicado: (1988)

Assessing the Influence of Benign Prostatic Hyperplasia (BPH) on Erectile Dysfunction (ED) among patients in Poland
por: Dutkiewicz, Sławomir, et al.
Publicado: (2012)

Relationship between Dietary Patterns with Benign Prostatic Hyperplasia and Erectile Dysfunction: A Collaborative Review
por: Russo, Giorgio Ivan, et al.
Publicado: (2021)

Calculated Tumor Volume Is an Independent Predictor of Biochemical Recurrence in Patients Who Underwent Retropubic Radical Prostatectomy
por: Tanaka, Nobumichi, et al.
Publicado: (2012)

Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid
por: Nakai, Yasushi, et al.
Publicado: (2014)

Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy
por: Tomioka, Atsushi, et al.
Publicado: (2015)

Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer
por: Miyake, Makito, et al.
Publicado: (2014)

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014)

Basic Fibroblast Growth Factor as a Candidate Tumor Marker for Renal Cell Carcinoma
por: Fujimoto, Kiyohide, et al.
Publicado: (1995)

A Case of Bisphosphonate-Related Osteonecrosis of the Jaw in a Patient with Subpontic Osseous Hyperplasia
por: Tsuji, Chiaki, et al.
Publicado: (2017)

Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia
por: Gotoh, Daisuke, et al.
Publicado: (2022)

Impact of combined pulmonary fibrosis and emphysema on surgical complications and long-term survival in patients undergoing surgery for non-small-cell lung cancer
por: Hata, Atsushi, et al.
Publicado: (2016)

Follow-up study of unilateral renal function after nephrectomy assessed by glomerular filtration rate per functional renal volume
por: Hosokawa, Yukinari, et al.
Publicado: (2014)

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction
por: Gacci, Mauro, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ca1fectlc8h5munjaun5em5jse